Latest Market News

Little Green Pharma has pushed back the Federal Court hearing for its Cannatrek acquisition to late May, setting a new timetable that includes a shareholder vote on May 22 and implementation targeted for June 1.

8common Limited reported a 7% rise in SaaS revenue to $1.2 million in Q3 FY26, backed by fresh government contracts and cost cuts. The fintech is on track to deliver full year EBITDA positive and maintain solid operational cash flow.

Santos delivered a steady first quarter with production up 3% year-on-year, driven by Barossa's initial cargoes and Pikka phase 1 nearing first oil. Free cash flow held firm at $383 million, while a key Moomba optimisation project received final investment approval.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.

Doctor Care Anywhere posted an 8.4% quarterly jump in consultations and sustained positive cashflow for the fourth consecutive quarter, while launching new digital health initiatives and reaffirming its medium-term revenue and profitability targets.

Burley Minerals has reignited interest in its Chubb Lithium Project in Quebec following a lithium price uptick and promising drilling results revealing both spodumene and rare pollucite mineralisation. The company is weighing strategic options including further exploration, joint ventures, or sale.

First Graphene has demonstrated a significant carbon reduction in cement roof tiles through a UK production trial with FP McCann, using graphene-enhanced cement to lower emissions and material use.

EQ Resources has launched a significant drilling campaign at its Mt Carbine Tungsten Mine aiming to upgrade resources and support mine life extension amid rising tungsten prices.

Tolu Minerals has raised AUD 23.75 million through convertible notes from Petrosea, reinforcing its capital position ahead of shareholder approval. The company is also shoring up diesel supplies to safeguard operations at its Tolukuma Gold Mine amid global fuel volatility, while early drilling results hint at further resource potential.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Aldoro Resources has achieved an exceptional ~99% strontium extraction from its Kameelburg Project ore using simple ambient-temperature acid leaching, positioning the asset as a rare, low-complexity source amid soaring global strontium prices and supply disruptions.

Barton Gold has launched a ~3,000m diamond drilling campaign at its Tunkillia project, aiming to upgrade resources and support a Mining Lease application by the end of 2026. The project builds on a strong May 2025 study projecting robust returns amid rising gold and silver prices.